Fomepizole in Ethylene Glycol Poisoning

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”>


CHAPTER 82 FOMEPIZOLE IN ETHYLENE GLYCOL POISONING


Fomepizole for the Treatment of Ethylene Glycol Poisoning


Brent J, McMartin K, Phillips S, et al. N Engl J Med. 1999;340(11):832–838


BACKGROUND


Ethylene glycol poisoning causes significant morbidity, including renal failure, damage to the central nervous system, and cardiovascular instability. Prior to this study the standard treatment of ethylene glycol poisoning included high-dose ethanol as a means of inhibiting the conversion of ethylene glycol into its toxic metabolites through alcohol dehydrogenase. Ethanol has concerning side effects including intoxication, hepatotoxicity, and hypoglycemia as well as a widely variable metabolism. Fomepizole is an inhibitor of alcohol dehydrogenase that, at the time of this study, was theorized to have similar clinical benefit as high-dose alcohol in the treatment of ethylene glycol poisoning without the toxic side effects.


OBJECTIVES


To determine the efficacy of fomepizole in the treatment of ethylene glycol poisoning.


METHODS


Prospective, open, multicenter study between 1995 and 1997.


Participants

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 14, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on Fomepizole in Ethylene Glycol Poisoning

Full access? Get Clinical Tree

Get Clinical Tree app for offline access